M. Schrappe, A. Reiter, M. Zimmermann, J. Harbott, W. Ludwig et al., Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995, Leukemia, vol.14, issue.12, pp.2205-2222, 1981.
DOI : 10.1038/sj.leu.2401973

A. Roy, M. Bradburn, A. Moorman, and J. Burrett, Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial, British Journal of Haematology, vol.90, issue.1, pp.35-44, 2005.
DOI : 10.1182/blood-2004-04-1389

K. Schultz, D. Pullen, H. Sather, J. Shuster, M. Devidas et al., Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG), Blood, vol.109, issue.3, pp.926-935, 2007.
DOI : 10.1182/blood-2006-01-024729

M. Arico, M. Valsecchi, B. Camitta, M. Schrappe, J. Chessells et al., Outcome of Treatment in Children with Philadelphia Chromosome???Positive Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.342, issue.14, pp.998-1006, 2000.
DOI : 10.1056/NEJM200004063421402

C. Oudot, M. Auclerc, M. Levy, R. Porcher, C. Piguet et al., Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study, Journal of Clinical Oncology, vol.26, issue.9, pp.1496-1503, 2008.
DOI : 10.1200/JCO.2007.12.2820
URL : https://hal.archives-ouvertes.fr/inserm-00435722

R. Ribeiro, A. Broniscer, G. Rivera, M. Hancock, S. Raimondi et al., Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts, Leukemia, vol.11, issue.9, pp.1493-1496, 1997.
DOI : 10.1038/sj.leu.2400749

B. Fine, M. Stanulla, M. Schrappe, M. Ho, S. Viehmann et al., Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia, Blood, vol.103, issue.3, pp.1043-1049, 2004.
DOI : 10.1182/blood-2003-05-1518

S. Chiaretti, X. Li, R. Gentleman, A. Vitale, K. Wang et al., Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation, Clinical Cancer Research, vol.11, issue.20, pp.117209-117228, 2005.
DOI : 10.1158/1078-0432.CCR-04-2165

D. Juric, N. Lacayo, M. Ramsey, J. Racevskis, P. Wiernik et al., Differential gene expression patterns and interaction networks in BCR-ABLpositive and -negative adult acute lymphoblastic leukemias, J Clin Oncol, issue.11, pp.251341-251350, 2007.
DOI : 10.1200/jco.2006.09.3534

A. De-labarthe, P. Rousselot, F. Huguet-rigal, E. Delabesse, F. Witz et al., Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study, Blood, vol.109, issue.4, pp.1408-1421, 2007.
DOI : 10.1182/blood-2006-03-011908

M. Yanada, J. Takeuchi, I. Sugiura, H. Akiyama, N. Usui et al., ???Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group, Journal of Clinical Oncology, vol.24, issue.3, pp.460-466, 2006.
DOI : 10.1200/JCO.2005.03.2177

B. Wassman, B. Wassmann, H. Pfeifer, N. Goekbuget, D. Beelen et al., Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL), Blood, vol.108, issue.5, pp.1469-77, 2006.
DOI : 10.1182/blood-2005-11-4386

J. Fuster, M. Bermudez, A. Galera, M. Llinares, D. Calle et al., Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia, Haematologica, vol.92, issue.12, pp.1723-1724, 2007.
DOI : 10.3324/haematol.11525

K. Schultz, W. Bowman, W. Slayton, A. Aledo, M. Devida et al., Improve early event free survival in children with philadelphia chromosome-positive acute lymphoblastic leukemia with intensive imatinib in combination with high dose chemotherapy: children's oncology group study AALL0031, Blood, vol.110, 2007.

A. Gajjar, R. Ribeiro, M. Hancock, G. Rivera, H. Mahmoud et al., Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia, Blood, vol.86, issue.4, pp.1292-1297, 1995.

A. Reiter, M. Schrappe, W. Ludwig, W. Hiddemann, S. Sauter et al., Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86, Blood, vol.84, issue.9, pp.3122-3155, 1994.

J. Sandlund, P. Harrison, G. Rivera, F. Behm, D. Head et al., Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia, Blood, vol.100, issue.1, pp.43-50, 2002.
DOI : 10.1182/blood.V100.1.43

A. Sharathkumar, E. Saunders, Y. Dror, M. Greenberg, S. Weitzman et al., Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia, Bone Marrow Transplantation, vol.33, issue.1, pp.39-45, 2004.
DOI : 10.1038/sj.bmt.1704319

U. Scheuring, H. Pfeifer, B. Wassmann, P. Bruck, B. Gehrke et al., Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment, Leukemia, vol.17, issue.9, pp.1700-1706, 2003.
DOI : 10.1038/sj.leu.2403062

F. Pane, G. Cimino, B. Izzo, A. Camera, A. Vitale et al., Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia, Leukemia, vol.22, issue.4, pp.628-663, 2005.
DOI : 10.1182/blood-2003-08-2958

P. Carpenter, P. Carpenter, D. Snyder, M. Flowers, J. Sanders et al., Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia, Blood, vol.109, issue.7, pp.2791-2793, 2007.
DOI : 10.1182/blood-2006-04-019836

A. Fielding and A. Goldstone, Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia, Bone Marrow Transplantation, vol.89, issue.5, pp.447-53, 2008.
DOI : 10.1182/blood-2007-02-073528